Header cover image

Egyptian (OMX) Pharma Industry Analysis

UpdatedJan 19, 2022
DataAggregated Company Financials
  • 7D-2.4%
  • 3M10.7%
  • 1Y10.2%
  • YTD0.4%

Over the last 7 days, the Pharma industry has dropped 2.4%, driven by a pullback from Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E of 6.3%. Meanwhile, MINAPHARM Pharmaceuticals actually outperformed within the industry, gaining 7.7% in the last week. This takes the industry's 12 month performance to a gain of 10%.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 19 Jan 2022ج.م13.5bج.م13.3bج.م1.8b6.3x
Fri, 17 Dec 2021ج.م12.8bج.م13.3bج.م1.8b5.9x
Sun, 14 Nov 2021ج.م12.1bج.م13.1bج.م1.8b5.9x
Tue, 12 Oct 2021ج.م12.9bج.م12.9bج.م1.8b5.5x
Thu, 09 Sep 2021ج.م13.5bج.م13.0bج.م1.8b5.1x
Sat, 07 Aug 2021ج.م13.5bج.م13.0bج.م1.8b5.2x
Fri, 30 Apr 2021ج.م12.6bج.م12.6bج.م1.7b5.3x
Mon, 01 Feb 2021ج.م12.6bج.م12.2bج.م1.6b6x
Thu, 05 Nov 2020ج.م12.5bج.م12.1bج.م1.6b6.3x
Sun, 09 Aug 2020ج.م12.8bج.م12.0bج.م1.6b5.8x
Sat, 02 May 2020ج.م12.3bج.م11.9bج.م1.5b5.4x
Tue, 04 Feb 2020ج.م14.9bج.م11.8bج.م1.4b7.3x
Fri, 08 Nov 2019ج.م11.0bج.م10.4bج.م1.1b7.4x
Thu, 01 Aug 2019ج.م12.3bج.م10.1bج.م1.1b15.6x
Sun, 05 May 2019ج.م12.3bج.م9.8bج.م1.1b13x
Wed, 06 Feb 2019ج.م12.3bج.م9.5bج.م1.1b10.1x
PE Ratio


Total Market Cap: ج.م12.3bTotal Earnings: ج.م1.1bTotal Revenue: ج.م9.5b0%0%0%3 Year10 Year

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 7.8x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 17% per year over the last three years, and revenues for these companies have grown 12% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Pharma industry?


Industry PE: Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 7.8x. This is likely because analysts are expecting annual earnings growth of 23%, which is higher than its past year's earnings growth of 8.7% per year.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 23% over the next 5 years. This is better than it's past earnings growth rate of 8.7% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MIPH MINAPHARM Pharmaceuticalsج.م156.377.7%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News